[REGN] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
03-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- 55.76%
YoY- 97.61%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 1,511,485 1,582,447 1,500,673 1,470,116 1,318,991 1,226,827 1,220,122 15.36%
PBT 585,398 554,767 565,605 525,850 432,289 341,527 365,881 36.83%
Tax 107,418 381,248 177,288 138,106 183,358 88,412 101,077 4.14%
NP 477,980 173,519 388,317 387,744 248,931 253,115 264,804 48.30%
Tax Rate -18.35% -68.72% -31.34% -26.26% -42.42% -25.89% -27.63% -
Total Cost 1,033,505 1,408,928 1,112,356 1,082,372 1,070,060 973,712 955,318 5.38%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin 31.62 10.97 25.88 26.38 18.87 20.63 21.70 28.55%
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
EPS 4.44 1.62 3.64 3.66 2.36 2.41 2.53 45.54%
EPS Diluted 4.16 1.49 3.32 3.34 2.16 2.19 2.27 49.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.